Spyre Therapeutics (SYRE) Non Operating Income (2015 - 2026)
Spyre Therapeutics (SYRE) posted Non Operating Income of $9.6 million for Q3 2026, down 79.0% from $45.71 million a year earlier but up 76.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Non Operating Income (2015 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Non Operating Income at Spyre Therapeutics was -$13.69 million; for FY2025, it came in at $54.34 million.
- Annual Non Operating Income shows a five-year compound annual growth rate of 147.3% (FY2020 to FY2025).
- In prior years, Spyre Therapeutics' Non Operating Income was $599,000 in FY2024, -$96.51 million in FY2023, $830,000 in FY2022 and -$11,000 in FY2021.
- Quarterly Non Operating Income has run from a low of -$57.83 million in Q2 2023 to a high of $45.71 million in Q3 2025 over five years.
- On a year-over-year basis, Non Operating Income increased in two of the last four quarters, with growth averaging 11.5%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $5.44 million (Q2 2026), -$23.36 million (Q1 2026) and -$5.36 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 9.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.60 Mn |
| Jun 30, 2026 | 5.44 Mn |
| Mar 31, 2026 | -23.36 Mn |
| Dec 31, 2025 | -5.36 Mn |
| Sep 30, 2025 | 45.71 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Mar 31, 2025 | 8.78 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | -13.62 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | 3.95 Mn |
| Dec 31, 2023 | -17.27 Mn |
| Sep 30, 2023 | -21.77 Mn |
| Jun 30, 2023 | -57.83 Mn |
| Mar 31, 2023 | 348,000.00 |
| Dec 31, 2022 | 378,000.00 |
| Sep 30, 2022 | 312,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 19,000.00 |
API Access
Spyre Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();